David Saloff
Chief Executive Officer
David is a serial healthcare and medical device entrepreneur with more than 30 years of industry experience, two IPOs, and over $70 million raised across his ventures. His career spans commercialization partnerships with Fortune 200 companies including Stryker, Allergan, and Anthem. David brings both the technical depth and the go-to-market track record to bring Revallis from prototype to category leader.
Robert Crousore
Strategic Sales Advisor
Robert is a healthcare commercialization executive with 35+ years building and scaling revenue organizations in health and wellness. As President of Magniant and through multiple successful exits, he has developed the go-to-market playbooks that Revallis is building on.
Aditya Kashyap
Strategic Marketing Advisor
Aditya is a product and growth executive who drove more than $1 billion in incremental revenue at Facebook and has led transformational growth initiatives at Tinder, Zynga, and Flickr. He brings the performance marketing expertise required to scale Revallis’s DTC channel efficiently.
Jorge Möller
Strategic Financial Advisor
Jorge is a seasoned financial executive with 20+ years across banking, fintech, and healthcare technology. He has a track record of fundraising support and CFO-level infrastructure development for growth-stage ventures.
Dr. Andy Kornstein
Chief Medical Officer
Dr. Kornstein is a board-certified plastic and reconstructive surgeon with 35+ years in practice. He provides medical authority and clinical validation for Revallis, and is actively engaged in the design of the company’s efficacy study protocol.
Nathan Iyer
Technology Advisor
Nathan is a multi-patent RF and electromagnetic engineering expert with 20+ years in medical devices, IC design, and AI-driven technologies. He previously served as CTO of IVIVI Technologies, an RF medical device company.
Suzy Couturier
Strategic Advisor
Suzy is a marketing strategist with a 30-year track record driving brand value across medical, professional, and consumer markets for DuPont, Pfizer, Inamed, and Allergan.
Melissa Gonzales
Strategic Advisor
Melissa is the former President of Women’s Health at Myriad Genetics, where she led more than $100 million in revenue growth over four and a half years. She has held executive roles at Medela, Smith & Nephew, and Align Technology, and was named a 2024 MM&M Woman of Distinction.